Suzy Im, Managing Partner at BDMT Global, a widely known name in global business development and an award-winning marketing transformation leader, is at the forefront of the rapidly advancing high-tech and medical industries. Suzy established Business Development & Marketing Transformation (BDMT) Global with an innovative business model that combines the two most critical functions for companies entering the U.S. market. In 2023, Suzy launched the Digitization, Automation, and Cross-Industry Collaboration (DAC) Global Connection Initiative to support industrial and medical sectors in need of urgent transformation. DAC became a new growth channel for leading APEC and U.S. companies seeking global collaboration opportunities, including cutting-edge AI, healthcare, medical device, robotics, and automation innovators.

In her 20+ years of experience, Suzy has worked with technology and healthcare enterprises and startups, including Siemens, GE, HP, Teradyne, and Samsung, as well as leading IT and medical industry analysts, influencers, and KOLs.

• Connect with Suzy on LinkedIn.
• Special Interview: Stagnation? It came with an Opportunity for Innovation.

Janice Dru-Bennett, Senior Global Business Development and Marketing Manager at BDMT Global and leader of the KOL network program. Janice, a strategic leader with 15+ years of experience, has held senior-level positions in marketing, business development and partnerships. Her industry experience spans from health and wellness to financial services, B2B & SaaS software, higher education, emerging technologies, innovation and more. Janice demonstrates a proven track record of helping clients and partners with data strategy and business transformation, delivering seamless experiences through integrated platforms, building and growing sales and marketing departments, and establishing key partnerships that positively impact revenues and profits.

As an entrepreneurial executive, she is passionate about solving problems, advancing healthcare solutions, supporting social impact initiatives, organizing events, and gathering global communities.

Sonal Matai is Managing Director and Regional President of North America at Karl Storz, where he leads 2,600+ employees across R&D, manufacturing, sales, marketing, and operations. With over 20 years of global experience in medical and consumer devices, he is a proven P&L leader known for driving business transformation, digitization, and customer-centric innovation. His mission is to improve health outcomes worldwide through impactful, scalable solutions.

Dr. Alexander J. Blood fulfills multiple roles at Boston’s Brigham and Women’s Hospital (BWH) and AIwithCare. He is a Cardiologist and Intensivist, in addition to serving as the Associate Director for the Accelerator for Clinical Transformation research group and Senior Clinical Investigator at Mass General Brigham’s Data Science Office.

Brad Waugh, Board Chair of Life Wear Technologies is the producer of the CryoMAX product which is the leading cold therapy system, utilizing the patented “Points of Cold” technology which allows it to last eight hours after freezing. CryoMAX is manufactured in the USA and is available in over 30,000 retail stores

Nihar Prasanna (Chief Business Officer BTNX and Partner & Investor Acunova Life Sciences) is a global healthcare executive with over two decades of experience in strategy, M&A, and innovation in the diagnostics industry. He is currently Chief Business Officer at BTNX Inc., a global leader in rapid point-of-care diagnostics, where he leads corporate strategy, business development, and transformation. Nihar also serves as Partner and Investor at Acunova Life Sciences, a healthcare-focused family office, where he oversees healthcare investments and advises diagnostics companies and private equity funds on growth and value creation. He previously held senior leadership roles at Roche and Werfen and serves on the Advisory Board of the Prasanna School of Public Health at Manipal University. Nihar holds a degree in life sciences and economics from the University of Wisconsin and an MBA from IESE Business School in Spain.

Dr. William Morice is President of Mayo Clinic Laboratories and Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. A globally recognized leader in diagnostic innovation, he oversees more than 60 labs and 3,000 staff while driving strategic growth through global partnerships and advanced testing capabilities. Dr. Morice has played a pivotal role in expanding Mayo Clinic’s global footprint and pioneering the future of laboratory medicine.

Sonal Matai is Managing Director and Regional President of North America at Karl Storz, where he leads 2,600+ employees across R&D, manufacturing, sales, marketing, and operations. With over 20 years of global experience in medical and consumer devices, he is a proven P&L leader known for driving business transformation, digitization, and customer-centric innovation. His mission is to improve health outcomes worldwide through impactful, scalable solutions.

Dr. Joseph Cambio is a leading urologist based in Rhode Island, serving as a Physician Partner and Urologist for Urologic Specialists of New England LLC and the Chief of Surgery/Chief Urologist of Landmark Medical Center. A pioneer in minimally invasive urology, he was the first in the state to adopt both UroLift and the PROCEPT Aquablation robotic platform, now performing the highest number of Aquablation procedures in New England. With over 20 years of clinical experience, Dr. Cambio is committed to advancing patient care through cutting-edge technology and innovation.

Brad Waugh, Board Chair of Life Wear Technologies is the producer of the CryoMAX product which is the leading cold therapy system, utilizing the patented “Points of Cold” technology which allows it to last eight hours after freezing. CryoMAX is manufactured in the USA and is available in over 30,000 retail stores.

Over the last seven years, Brad navigated his company, Life Wear Technologies, through tariffs from the first Trump administration, into the Biden era, and now into the current Trump administration. During that time, he relocated five manufacturing facilities out of Guangzhou China into India, Pakistan, Vietnam, Cambodia, and the USA. He ended up buying the facilities in both Vietnam and India. Brad successfully negotiated foreign trade zones in Florida, Rhode Island, and Texas. In order to set up successfully in the USA, Brad arranged State training grants, distribution/warehouse partners, shipping contracts, tax abatements, manufacturing credits, and the political contacts at the State & Federal levels to smooth the process to a successful conclusion.

Life Wear Technologies has successfully verticalized and distributed its product & distribution into multiple locations, and the move to the USA resulted in a 30% decrease in COGS, while reducing the turnaround on orders from 90 days to 14 days. In addition, the company has adopted a “just in time” production philosophy which has reduced warehouse space by 50%. This five year odyssey has resulted in stronger relationships with AMAZON, Walmart, Walgreens, Cardinal Health, and McKesson, to name a few, for the production of Class I medical devices. The company is now working diligently to move its Class II medical devices.

Jeff Rosedale, Ph.D., Partner at BakerHostetler is one of the firm’s most experienced IP partners, with more than 20 years as a registered U.S. patent lawyer and 10 years as an R&D chemical engineer. His areas of concentration include developing IP strategies and international patent portfolios for many early-stage companies covering a wide variety of technical areas, including the life sciences, advanced materials and consumer products.

Jeff has also negotiated numerous license agreements on behalf of clients and routinely provides strategic patent prosecution guidance and patent diligence advice in connection with high value transactions. In view of his breadth of experience, he is a partner in both of our Patent Prosecution Groups – IP Life Sciences and Advanced Materials as well as IP Technology.

Jeff works at the cutting edge of science and technology to develop and protect clients’ intellectual property. He helps clients, including many startups and early-stage companies, draft IP-critical agreements such as licenses, joint-development agreements and joint-venture agreements. He also works with clients to develop IP strategies, patent portfolios and licensing strategies, utilizing his extensive technical background. Similarly, Jeff advises venture capital and private equity firms by providing critical evaluations of the IP portfolios of their target investments

Jeff’s expertise covers topics including:

• IP strategy for global companies entering the U.S. market
• Licensing and commercialization of technology in the U.S.
• Patent portfolio planning and management during U.S. expansion
• Trade secret and confidentiality protections for cross-border collaborations

Ny’Nika McFadden, PhD, is Assistant Professor of Public Health at Texas State University. With numerous publications and industry presentations, her research interests include Chronic Disease Prevention, Chronic Disease Self-Management, Mobile Applications, Diabetes Technologies, Patient Engagement, Patient-Provider Communication, Patient Education, Medication Adherence, and Health Literacy.

Pat Merryweather-Arges is Executive Director of Project Patient Care, a not for profit bringing forward the voice of the patient, family, and caregiver to advance healthcare. The organization works to prevent medical errors and cares deeply about ensuring that every patient gets the right care at the right time. Pat also works globally on healthcare improvements with Rotary International, as a past Board Vice President (2023-2024) and Director (2022-2024).

John W. Robitscher, MPH, is Chief Executive Officer of the National Association of Chronic Disease Directors (NACDD), an organization that works to serve and represent every chronic disease division in all U.S. states and territories. John also served as the executive director of the Henry W. Grady Foundation and as a fellow at the Centers for Disease Control and Prevention’s National Center for Chronic Disease Prevention and Health Promotion. He is the former chair of the Association of State and Territorial Health Officials’ Affiliate Council, and a board member of the Population Health Alliance.

Stacey Simms is author of award-winning books “The World’s Worst Diabetes Mom” and its sequel “Still the World’s Worst Diabetes Mom” as well as host of Diabetes Connections podcast projects for Type 2 and Type 1 (T1D) communities. Diabetes Connections has also presented Mom’s Night Out community events in cities around the U.S. Before launching the podcast in 2015, Stacey had a thriving career in local TV and radio news, winning AP and local awards for her time on-air. Stacey’s son, Benny, was diagnosed with type 1 in 2006, just before he turned two. He’s now a college sophomore attending a school 600 miles away from home. Stacey’s daughter has been outspoken about the experience of siblings of kids with T1D. 

Yeaseul Park is CEO and Co-Founder of Orange Biomed, a global innovator with the mission to solve unmet diabetes-focused healthcare needs with cutting-edge technology, and the vision to expand access to innovative care solutions for chronic diseases. “By collaborating with other innovators shaping the future of healthcare, we aim to stay close to patients, shifting from lab-centered to patient-centered care to improve health outcomes,” said Park. Orange Biomed aims to discover solutions with fellow innovators to solve gaps in lab testing and advance the future of healthcare.

Dr. Julia M., is Associate Professor of Medicine at the Division of Endocrinology and Diabetology at Medical University of Graz and Deputy Head of the Diabetes Outpatient Clinic. She leads the Diabetes Technology Research Unit at the university and she has published over 100 peer-reviewed scientific papers, receiving several national and international awards in the field of diabetes technology.

Nassir R., MD, MPH, is Associate Professor, Vascular Interventional Radiology, at Washington University in St. Louis. He brings expertise in devices in the field of interventional radiology (IR), with specific areas of focus in embolization, prostatic artery embolization, and portal hypertension. He is an editorial board member for JVIR (a leading journal in IR) and AJR (a leading journal in radiology). 

Richard S., MD, is Chief of Urology at John T. Mather Hospital. A urologist, surgeon leader and urology service-line growth specialist, his experience spans a decades worth proven track record in practice growth, patient happiness, education, research, risk management, and technology early adoption. He is the Past President of the Suffolk County Medical Society and former Urologist at Long Island Community Hospital and Attending Urologist at NYU Grossman School of Medicine.

Ken T. is head of Global Product Strategy & Software Medical Devices (SaMD) at a leading biopharmaceutical company. As an Advisor, he is an experienced Vice President in Healthcare with a demonstrated history of working in the Life Sciences and Digital Health. He is skilled in Business Process, Medical Devices, Databases, IT Strategy, Experience Design, and Professional Services. 

Dr. Alexander B. fulfills multiple roles at Boston’s Brigham and Women’s Hospital (BWH). He is a Cardiologist and Intensivist, in addition to serving as the Associate Director for the Accelerator for Clinical Transformation research group and Senior Clinical Investigator at Mass General Brigham’s Data Science Office.

Dr. Danny L. serves as the Chief Medical Informatics Officer at Johns Hopkins Community Physicians. In 2015, Dr. L received the Innovations in Clinical Care Award for his work at Johns Hopkins Community Physicians. His specialties include internal medicine, information technology, computer networking, EHR/EMR, healthcare technology, and a certified Epic physician builder.